Companies: 10,795·Total market cap: $144.5T
Kudelski S.A.

Kudelski S.A.

KDCXFOTCTechnology● Active
$1.62
+$0.00(+0.00%)
Market Cap$83507562
P/E Ratio
52W High$1.62
52W Low$1.15
Overview

Kudelski S.A. (KDCXF) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · KDCXF · as of 2026-06-09

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.38B$0.38B$0.41B$0.71B$0.76B
Cost of Revenue$0.34B$0.29B$0.08B$0.63B$0.65B
Gross Profit$0.05B$0.09B$0.33B$0.10B$0.10B
Gross Margin %(computed)12.70%24.73%80.39%14.49%13.38%
Operating Expenses
R&D Expenses$0.11B$0.01B$0.12B$0.14B$0.13B
G&A Expenses$0.00B$0.04B$0.06B$0.05B$0.05B
Total Operating Expenses$0.08B$0.22B$0.35B$0.11B$0.10B
Operating Income($0.03B)($0.12B)($0.03B)$0.00B$0.03B
Operating Margin %(computed)-8.69%-31.32%-6.58%0.12%4.00%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.00B$0.02B$0.01B$0.01B$0.01B
Income Before Tax($0.04B)($0.14B)($0.03B)($0.01B)$0.02B
Income Tax Expense$0.01B$0.01B$0.00B$0.01B$0.00B
Net Income($0.04B)$0.01B($0.03B)($0.02B)$0.01B
Net Margin %(computed)-11.57%2.97%-7.14%-2.93%1.93%
Per Share & EBITDA
EPS (Basic)$-0.79$0.20$-0.53$-0.37$0.26
Wtd Avg Shares0.06B0.06B0.06B0.06B0.06B
EBITDA($0.02B)($0.01B)$0.02B$0.03B$0.06B
EBITDA Margin %(computed)-5.46%-3.09%5.09%4.34%7.60%

Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B

Explore more Kudelski S.A. data

About Kudelski S.A. (KDCXF) Income Statement

Kudelski S.A. (KDCXF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, KDCXF reported revenue of $0.38B, gross profit of $0.05B (gross margin 12.70%), and net income of ($0.04B) — a net profit margin of -11.57%.

Frequently asked questions

KDCXF · 4 questions

Kudelski S.A. (KDCXF) reported revenue of $0.38B for 2025, up 0.1% year-over-year.

KDCXF revenueKDCXF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09